JP2022525914A5 - - Google Patents
Info
- Publication number
- JP2022525914A5 JP2022525914A5 JP2021556394A JP2021556394A JP2022525914A5 JP 2022525914 A5 JP2022525914 A5 JP 2022525914A5 JP 2021556394 A JP2021556394 A JP 2021556394A JP 2021556394 A JP2021556394 A JP 2021556394A JP 2022525914 A5 JP2022525914 A5 JP 2022525914A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- seq
- amino acid
- acid sequence
- plyss2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962822386P | 2019-03-22 | 2019-03-22 | |
| US62/822,386 | 2019-03-22 | ||
| US201962832708P | 2019-04-11 | 2019-04-11 | |
| US62/832,708 | 2019-04-11 | ||
| US201962849093P | 2019-05-16 | 2019-05-16 | |
| US62/849,093 | 2019-05-16 | ||
| US201962898379P | 2019-09-10 | 2019-09-10 | |
| US62/898,379 | 2019-09-10 | ||
| US202062965720P | 2020-01-24 | 2020-01-24 | |
| US62/965,720 | 2020-01-24 | ||
| PCT/US2020/024051 WO2020198073A1 (en) | 2019-03-22 | 2020-03-20 | Method of treating infective endocarditis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525914A JP2022525914A (ja) | 2022-05-20 |
| JP2022525914A5 true JP2022525914A5 (https=) | 2023-03-16 |
Family
ID=72611751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556394A Pending JP2022525914A (ja) | 2019-03-22 | 2020-03-20 | 感染性心内膜炎を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220160842A1 (https=) |
| EP (1) | EP3941504A4 (https=) |
| JP (1) | JP2022525914A (https=) |
| KR (1) | KR20210141667A (https=) |
| CN (1) | CN114025782A (https=) |
| AU (1) | AU2020244764A1 (https=) |
| BR (1) | BR112021018219A2 (https=) |
| CA (1) | CA3134154A1 (https=) |
| IL (1) | IL286389A (https=) |
| MX (1) | MX2021011469A (https=) |
| WO (1) | WO2020198073A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023023560A1 (en) * | 2021-08-17 | 2023-02-23 | Contrafect Corporation | New uses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100863692B1 (ko) * | 2006-12-08 | 2008-10-15 | 울산대학교 산학협력단 | 퇴행성질환 및 염증질환에 대한 예방치료 효과를 갖는7-하이드록시-6-메톡시-1,2,3,4-테트라하이드로이소퀴놀린유도체 |
| CA2833409A1 (en) * | 2011-04-21 | 2012-10-26 | The Rockefeller University | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| EP2699689A4 (en) * | 2011-04-21 | 2014-12-17 | Univ Utrecht Holding Bv | STREPTOCOCCUS BACTERIOPHAGEN LYSINE FOR THE TREATMENT OF GRAM-POSITIVE BACTERIA IN PETS AND UTILITIES |
| KR20210121313A (ko) * | 2012-05-09 | 2021-10-07 | 콘트라펙트 코포레이션 | 그람 양성 박테리아에 대한 박테리오파지 리신과 항생제의 병용물 |
| KR20200023521A (ko) * | 2012-05-09 | 2020-03-04 | 콘트라펙트 코포레이션 | 박테리오파지 리신을 이용한 생물막의 예방, 붕괴 및 치료 |
| AU2016324307B2 (en) * | 2015-09-17 | 2021-10-21 | Contrafect Corporation | Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby |
| KR20190004799A (ko) * | 2016-05-12 | 2019-01-14 | 콘트라펙트 코포레이션 | 항균 폴리펩티드의 최소 억제 농도를 평가 및 탐지하기 위한 배지미량희석법 |
| CA3069679A1 (en) * | 2017-07-10 | 2019-01-17 | Contrafect Corporation | Blood component potentiation of lytic protein anti-bacterial activity and methods and uses thereof |
-
2020
- 2020-03-20 CA CA3134154A patent/CA3134154A1/en active Pending
- 2020-03-20 CN CN202080037982.5A patent/CN114025782A/zh active Pending
- 2020-03-20 WO PCT/US2020/024051 patent/WO2020198073A1/en not_active Ceased
- 2020-03-20 JP JP2021556394A patent/JP2022525914A/ja active Pending
- 2020-03-20 MX MX2021011469A patent/MX2021011469A/es unknown
- 2020-03-20 EP EP20777214.6A patent/EP3941504A4/en active Pending
- 2020-03-20 AU AU2020244764A patent/AU2020244764A1/en not_active Abandoned
- 2020-03-20 US US17/440,916 patent/US20220160842A1/en not_active Abandoned
- 2020-03-20 KR KR1020217034201A patent/KR20210141667A/ko active Pending
- 2020-03-20 BR BR112021018219A patent/BR112021018219A2/pt unknown
-
2021
- 2021-09-14 IL IL286389A patent/IL286389A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2363489C9 (ru) | Способ применения антибиотиков | |
| Raja et al. | Daptomycin | |
| JP2022058682A5 (https=) | ||
| JP2022163214A5 (https=) | ||
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| NO320884B1 (no) | Anvendelse av lysostafin eller variant derav til fremstilling av et medikament til behandling av infeksjoner. | |
| RU2011130278A (ru) | Новые противобактериальные средства для лечения грамположительных инфекций | |
| JPH11508265A (ja) | 抗生物質抵抗性グラム陽性細菌の制御および感染治療の方法 | |
| Chambers | In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a | |
| JP2012501349A5 (https=) | ||
| JP2021527699A5 (https=) | ||
| IL275795B1 (en) | Medical bacteriophage preparations for the treatment of staphylococcus infection | |
| EP1107722B1 (en) | A method for the treatment of staphylococcal infection | |
| RU2004118716A (ru) | Лечение инфекции, вызываемой микроорганизмами | |
| JP2022525914A5 (https=) | ||
| US10125167B2 (en) | Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics | |
| Brauers et al. | Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations | |
| Eliopoulos et al. | Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin | |
| Pittet et al. | Infective endocarditis and glycopeptides | |
| RU2021127055A (ru) | Способ лечения инфекционного эндокардита | |
| JP2022526624A5 (https=) | ||
| Karp et al. | Management of infections in neutropenic patients: new opportunities and emerging challenges | |
| CN114615991B (zh) | 作为用于抗微生物剂的佐剂的纤维蛋白原和疗法 | |
| Dharshini | PHARMACOECONOMIC EVALUATION OF VANCOMYCIN AND TEICOPLANIN | |
| Sujatha | Drug treatment of MRSA infections. |